and hemoptysis complicated the course of PE. Secondary prophylaxis with OA and international normalized ratio maintenance between 2 and 3 are being successfully continued.
The presented case report shows a poorly investigated problem, demonstrating the imperative for a better understanding of the efficacy of antithrombotic measures used in patients with trauma and documented AT deficiency. According to the existing guidelines, thromboprophylaxis with LMWH should be started, if possible, in patients with trauma and prolonged immobilization with at least 1 risk factor of venous thromboembolism like the AT deficiency. 1 Enoxaparin appeared to be insufficient in producing its major anticoagulant effect by activating AT, even at higher than the recommended dosage. This case provides further evidence that enoxaparin and related drugs require AT for their clinical efficacy. To the Editor:
The following is a case report that may be deemed important by trauma patients with known antithrombin (AT) deficiency and may be helpful to physicians treating similar cases.
A 39-year-old man with normal, stable blood pressure was admitted to the cardiopulmonary intensive care unit due to pulmonary embolism (PE) and deep venous thrombosis (DVT) diagnosed by spiral computed tomography. In 1999, a hereditary AT deficiency was confirmed in the presented case (AT activity and AT antigen concentration were 58% [normal value = 80%-120%] and 72% [normal value = 73%-130%] respectively). The AT test was conducted because his twin sister was also diagnosed with having a similar PE and DVT, also exhibited AT deficiency (type II). In 2006, the patient had a plaster cast around his knee due to knee injury and his primary antithrombotic prophylaxis included administration of low-molecular weight heparin (LMWH; 80 mg of enoxaparin administered subcutaneously once a day-patient's weight was 80 kg). Despite prophylaxis, which was started at the time of plaster cast application and continued during the period of immobilization, signs and symptoms of PE and DVT occurred after 6 weeks of treatment. Due to severe acute onset of PE, the patient was successfully treated with unfractionated heparin administered in constant drip, repeated infusions of AT concentrate, and oral anticoagulants (OA), which were started after stable therapeutic prolongation of activated partial thromboplastin time. Transient pulmonary hypertension documented by echocardiography
